For Investors

JSC Olainfarm is a pharmaceutical company. It is engaged in the manufacturing of finished drug forms and chemical-pharmaceutical products in the Baltics. The group operates in Medicine Production segment, Wholesale segment, Retail segment, Compression Materials segment and Other segments. Olainfarm Group exports to more than 50 countries worldwide and its main export markets are Russia, Ukraine, Belarus, The Netherlands, Kazakhstan, Uzbekistan, and Germany. Farthest export market – Australia.

The share capital of JSC Olainfarm comprises 14,085,078 ordinary shares registered in the Nasdaq CSD depository and included on the Official Baltic List at Nasdaq Riga.

JSC Olainfarm is one of the most popular companies on Baltic’s equity market and its shares are available to local and foreign investors.

For Investors